Meet Michael Polansky: The Quiet Force Behind Outer Biosciences and Lady Gaga
Michael Polansky is not your typical tech entrepreneur, especially in an industry often characterized by larger-than-life personalities. Enjoying a serene afternoon on a patio outside a bustling bakery in Mill Valley, California, Polansky’s amiable demeanor and casual appearance often mask his influential roles as both a co-founder of the innovative AI and biology startup Outer Biosciences and a creative partner to pop icon Lady Gaga.
A Unique Journey from Minnesota to Silicon Valley
Growing up in Minnesota, Polansky seemed destined for a different life. He pursued applied mathematics and computer science at Harvard University, graduating in 2006. His early career took him to Bridgewater Associates, a hedge fund where he learned vital lessons, yet ultimately decided it wasn’t his calling.
A chance reunion with Sean Parker’s assistant led to a pivotal dinner in New York, which spurred Polansky to jump into the bustling tech scene of San Francisco, marking the beginning of his impactful career.
Building a Legacy in Life Sciences
At Founders Fund, during a critical time in Silicon Valley, Polansky thrived. His next big leap was joining Parker’s family office, where he honed his skills in investment and philanthropy. He played a significant role in the Parker Institute for Cancer Immunotherapy, where he served until circumstances led him in a different direction due to the pandemic.
Life took an exciting turn for Polansky when he met Lady Gaga in late 2019 at a birthday celebration. Her mother, Cynthia Germanotta, had long hoped to connect the two due to shared interests in philanthropy and innovation.
Innovating with Outer Biosciences
Co-founding Outer Biosciences in 2022, Polansky aimed to revolutionize how scientists conduct biological experiments. The company has notably focused on extending the viability of living human tissue for over a month, a groundbreaking achievement that allows researchers to observe biological processes in real-time, such as collagen remodeling and pigmentation changes.
Instead of synthetic models, Outer Biosciences uses human skin sourced ethically from non-profit biobanks. Polansky emphasizes that each donor’s privacy is strictly maintained, with samples fully de-identified before they reach the lab.
The Science Behind the Innovation
Polansky explains that the startup’s unique approach hinges on using AI to predict which chemicals may benefit skin biology. By feeding the data obtained from human tissue experiments back into its AI model, Outer Biosciences accelerates the discovery of new skin-active ingredients significantly.
With a growing database that includes insights into a limited number of FDA-approved drugs, Outer Biosciences is venturing into new territories in skin care. The startup plans to collaborate with beauty and pharmaceutical companies, bypassing the extensive FDA approval process needed for clinical drugs.
Future Outlook: What Lies Ahead
As of now, Outer Biosciences has successfully raised approximately $23 million and aims to expand its team. Polansky is enthusiastic about the prospect of gaining recognition for their scientific contributions, noting, “We want to start working in public now.”
While Outer Biosciences is not the sole player in this space, its method of using actual human tissue sets it apart. Competing entities like Vivodyne are also exploring similar paths, receiving significant funding recently to advance their technologies.
With a clear vision and innovative approaches, Michael Polansky’s dual legacy as a business leader and partner to Lady Gaga continues to unfold, showcasing how creativity and science can intersect in transformative ways.
